{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:47:45Z","timestamp":1758041265656,"version":"3.44.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ajog.2017.05.005","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T23:30:19Z","timestamp":1494545419000},"page":"232-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lifetime cancer risk with progestin and estrogen oral contraceptives and hormone therapy"],"prefix":"10.1016","volume":"217","author":[{"given":"Ellen C.G.","family":"Grant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2017.05.005_bib1","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.ajog.2017.02.002","article-title":"Lifetime cancer risk and\u00a0combined oral contraceptives: the Royal College of General Practitioners\u2019 oral contraception study","volume":"216","author":"Iversen","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.005_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/13590849862221","article-title":"A\u00a0methodological review of the Royal College of General Practitioners\u2019 oral contraception study","volume":"8","author":"Galbraith","year":"1998","journal-title":"J\u00a0Nutr Environ Med"},{"key":"10.1016\/j.ajog.2017.05.005_bib3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1470-2045(15)00278-8","article-title":"Endometrial cancer with progestogen and estrogen oral contraceptives","volume":"26","author":"Grant","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajog.2017.05.005_bib4","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(14)61687-1","article-title":"Menopausal hormone use and ovarian cancer risk. Individual participant meta-analysis of 52 epidemiological studies","volume":"385","year":"2015","journal-title":"Lancet"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817306105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817306105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:17:22Z","timestamp":1757589442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937817306105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":4,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0002937817306105"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2017.05.005","relation":{},"ISSN":["0002-9378"],"issn-type":[{"type":"print","value":"0002-9378"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lifetime cancer risk with progestin and estrogen oral contraceptives and hormone therapy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2017.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2017.02.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}